Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Clinical trial NCT01922258 · COMPLETED
Trial details
- NCT number
- NCT01922258
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2017-03-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.